ReGen Biologics' CMI type I collagen implant to hit Spanish markets
This article was originally published in Clinica
Executive Summary
As part of its ongoing European expansion strategy, ReGen Biologics has appointed two Spanish companies as exclusive distributors of ReGen's CMI type I collagen implant in Spain. Under the terms of the separate, two-year agreements, Barcelona-based Polymedic 2000 will cover the Catalan region and the Balearic Islands, while Hoscenter, of Madrid, will manage all other areas of Spain. The contracts will also give both Spanish companies non-exclusive rights to market ReGen's SharpShooter tissue repair system, used in meniscus suturing procedures.